Add BrightSurf on Google Email

Vision via sound for the blind

Researchers developed 'acoustic touch' smart glasses that translate visual information into distinct sound icons, enhancing the ability of blind or low-vision individuals to navigate their surroundings. The technology significantly improved object recognition and reaching abilities, empowering independence and quality of life.

SourceUniversity of Technology Sydney·JournalPLOS ONE·TypeRandomized controlled/clinical trial·DateOct 25, 2023

Few children – especially those with safety-net insurance – get vision checked at checkups

A new study found that fewer than a third of children have had their vision checked in the past year, with uninsured and public-insured kids having lower rates than privately insured peers. The disparity in screening rates is linked to disparities in primary care visits focused on prevention and early detection.

SourceMichigan Medicine - University of Michigan·JournalJAMA Ophthalmology·TypeData/statistical analysis·DateAug 21, 2023

New study reveals reptiles’ spontaneous association between vision and hearing

A new study reveals that reptiles demonstrate spontaneous associations between visual and auditory information, including tortoises associating low sounds with large shapes and high pitch sounds with small shapes. This discovery shows how brains are prepared to predict visuo-acoustic correspondences likely to occur in the natural world.

SourceQueen Mary University of London·JournalBiology Letters·DateJul 20, 2023

NEW STUDY: Discovery of chemical means to reverse aging and restore cellular function

A team of scientists at Harvard Medical School has identified six chemical cocktails that can restore cellular aging and rejuvenate human cells. The study builds upon the discovery of Yamanaka factors, which can convert adult cells into induced pluripotent stem cells, raising hopes for treating age-related diseases and injuries. The im...

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJul 12, 2023

Tiny device mimics human vision and memory abilities

Researchers created a small device that captures, processes, and stores visual information in a similar way to humans. This technology uses analog processing, reducing energy consumption and enhancing performance, with potential applications in bionic vision, autonomous operations, and advanced forensics.

SourceRMIT University·TypeExperimental study·DateJun 14, 2023

Eye drops slow nearsightedness progression in kids, study finds

A new clinical trial found that low-dose atropine eye drops are effective in slowing the progression of nearsightedness in children. The treatment showed significant improvements in limiting eyeglass prescription changes and inhibiting elongation of the eye, with a daily drop in each eye being enough to make a difference.

SourceOhio State University·JournalJAMA Ophthalmology·TypeRandomized controlled/clinical trial·DateJun 1, 2023

Researchers devise a simpler way to mimic aspects of human vision

Researchers devise a simpler way to mimic aspects of human vision by extracting key optical measurements from computer models of the human eye and designing a simple optical system. The new design achieves similar image quality to the human visual system without requiring aspherical components, paving the way for more efficient devices.

SourceOptica·DateMay 16, 2023

New gene-editing technique reverses vision loss in mice

Researchers have successfully restored vision in mice with retinitis pigmentosa using a new CRISPR-based genome editing technique. The PE SpRY system corrected genetic mutations and restored normal electrical responses to light, preserving vision into old age. This breakthrough offers potential for treating inherited blindness.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateMar 17, 2023

Discovery suggests new way to prevent common causes of vision loss

UVA scientists have discovered a new contributor to abnormal blood vessel growth in the eye, which could lead to new treatments for macular degeneration and other vision loss conditions. The discovery identifies a key protein that determines VEGF levels, blocking it has reduced VEGF levels significantly without unwanted side effects.

SourceUniversity of Virginia Health System·JournalSignal Transduction and Targeted Therapy·DateFeb 24, 2023

CityU neuroscientists identify a small molecule that restores visual function after optic nerve injury

A research team led by Dr. Eddie Ma Chi-him identified a therapeutic small molecule M1 that increases mitochondrial dynamics and sustains long-distance axon regeneration, restoring visual functions in mice. Regenerated axons elicited neural activities and survived for four weeks after optic nerve injury.

SourceCity University of Hong Kong·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 20, 2023

Black and hispanic patients treated for retinal detachment with surgery had worse vision results than white patients

Researchers at Boston Medical Center discovered that Black and Hispanic patients had significantly worse vision outcomes after surgical treatment for retinal detachment compared to their White counterparts. The study suggests higher rates of proliferative vitreoretinopathy (PVR) may contribute to these findings.

SourceBoston Medical Center·JournalCanadian Journal of Ophthalmology·DateJan 17, 2023

Prevalence of vision impairment in older adults

More than one-quarter of U.S. adults aged 71 and older had vision impairment in 2021, according to a nationally representative survey study. The prevalence of vision impairment was associated with factors such as older age, lower education and income, non-white race, and Hispanic ethnicity.

SourceJAMA Network·JournalJAMA Ophthalmology·DateJan 12, 2023

Mount Sinai researchers first to identify that two separate eye diseases may contribute to common blinding eye condition

Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalEye·TypeObservational study·DateJan 9, 2023

Blinding eye disease strongly associated with serious forms of cardiovascular disease

A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalBMJ Open Ophthalmology·TypeImaging analysis·DateNov 17, 2022

Popular herbicide weakens bumblebees’ color vision

A study by Finnish researchers found that exposure to the herbicide glyphosate impairs bumblebees' fine color vision, affecting their ability to learn and remember connections between colors and tastes. This weakened color vision can severely impact bumblebees' foraging and nesting success.

SourceUniversity of Turku·JournalScience of The Total Environment·DateOct 13, 2022

Powerful enzyme that tamps down inflammation holds promise for protecting the eyes in diabetes, premature birth

Researchers found that increasing arginase 1 availability helps alleviate unhealthy responses and interrupt destructive inflammation in diabetic retinopathy and retinopathy of prematurity. This is achieved by reducing L-arginine levels, which in turn reduces inducible nitric oxide synthase activity.

SourceMedical College of Georgia at Augusta University·JournalCell Death and Disease·DateOct 12, 2022

Gene therapy rapidly improves night vision in adults with congenital blindness

Researchers at the University of Pennsylvania School of Medicine have developed a gene therapy that rapidly restores night vision in adults with LCA, a common form of congenital blindness. The treatment has been shown to improve rod-based visual functions and correct severe visual deficits in patients.

SourceUniversity of Pennsylvania School of Medicine·JournaliScience·TypeRandomized controlled/clinical trial·DateOct 10, 2022